The Alexandre de Moraes vs. X saga continues. It seemed it might be over, and that the ban in Brazil might get lifted after the social media company complied with the demands of the country’s Supreme Court.
And that included paying fines, which X owner Elon Musk last Friday said had been done. But now Justice Moraes claims that the payment was made to the wrong bank and needs to be transferred to the proper one – and besides, even when that issue is settled, the prosecutor general will have to be consulted before making a decision on restoring X in Brazil.
The first time X asked the Brazilian Supreme Court to allow it to resume business was on September 16, but Moraes at that time said that the fines still had to be paid.
The platform was blocked in August, as a result of an ever-escalating clash, always with Moraes as the main protagonist acting on behalf of Brazil. Since early 2024, X and Musk tried to resist censorship requests coming from Moraes and revealed some of the mechanisms behind it that were supposed to be kept from the public. […]
— Read More: reclaimthenet.org
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.